Cover Image
Market Research Report

Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User - Global Forecast to 2025

Published by MarketsandMarkets Product code 929400
Published Content info 169 Pages
Delivery time: 1-2 business days
Price
Back to Top
Digital Pathology Market by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End User - Global Forecast to 2025
Published: March 23, 2020 Content info: 169 Pages
Description

"The digital pathology market is projected to grow at a CAGR of 13.2% during the forecast period (2020-2025)."

The global digital pathology market is projected to reach USD 1,139.8 billion by 2025 from USD 613.6 billion in 2020, at a CAGR of 13.2% during the forecast period. The key factors driving the growth of this market include the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development & companion diagnostics, and increasing initiatives by industry players. However, the high cost of digital pathology systems is expected to restrict market growth to a certain extent.

"Adoption of artificial intelligence is expected to increase during the forecast period."

The adoption of AI in healthcare has been rising in recent years due to its ability to optimize clinical processes, thereby solving a variety of problems in the healthcare industry. AI helps patients receive correct diagnosis in a timely manner, maximize hospital efficiency, and reduce the waiting time for patients, thereby enhancing overall healthcare. AI helps in collecting, storing, and normalizing data along with tracing its lineage.

"The software segment will grow at the highest rate during the forecast period."

On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the digital pathology market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe, and the high cost of scanners. On the other hand, the software segment is projected to witness the highest growth rate during the forecast period, due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.

"By type, the human pathology segment accounted for the largest share of the digital pathology market in 2019."

On the basis of type, the global digital pathology market is segmented into human and veterinary pathology. The human pathology segment accounted for the largest share of the digital pathology market in 2019. The increasing number of cancer research activities and growing collaborations between academic research institutes, universities, and pathology laboratories are driving the increased uptake of digital systems in human pathology.

"The market in North America is projected to witness the highest growth rate during the forecast period (2020-2025)."

North America is projected to register the highest growth during the forecast period. This large share can be attributed to factors such as the rising prevalence of cancer and increasing initiatives by industry players. On the other hand, the Asia Pacific region is expected to grow at the second-highest CAGR during the forecast period. Factors such as a large patient population, shortage of pathologists, increasing initiatives in the healthcare industry by key market players, and rising adoption of advanced technologies for disease diagnosis are driving the growth of the digital pathology market in this region.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type (Supply-side): Tier 1: 29%, Tier 2: 37%, and Tier 3: 34%
  • By Category (Demand-side): Pharmaceutical & Biotechnology Companies: 55%, Hospitals and Reference Laboratories: 35%, and Academic & Research Institutes: 10%
  • By Designation: C-level: 35%, Director-level: 25%, and Managers: 40%
  • By Region: North America: 35%, Europe: 32%, Asia: 22%, and the RoW: 11%

Leica Biosystems (US), Koninklijke Philips (Netherlands), and Hamamatsu Photonics K.K. (Japan) are the leading players in the global digital pathology market. Other notable players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (Spain).

Research Coverage:

The report analyzes the digital pathology market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the digital pathology market. The report analyzes the market based on the product, type, application, end user, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the digital pathology market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of digital pathology solutions across regions.
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the digital pathology market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the digital pathology market.
Table of Contents
Product Code: HIT 2608

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
    • 1.2.1. INCLUSIONS AND EXCLUSIONS
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Break down of primary sources
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. DIGITAL PATHOLOGY MARKET OVERVIEW
  • 4.2. NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT (2019)
  • 4.3. GEOGRAPHICAL SNAPSHOT OF THE DIGITAL PATHOLOGY MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing adoption of digital pathology to enhance lab efficiency
      • 5.2.1.2. Rising prevalence of cancer
      • 5.2.1.3. Growing applications of digital pathology in drug development and companion diagnostics
      • 5.2.1.4. Increasing initiatives by industry players
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. High cost of digital pathology systems
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Introduction of affordable scanners for private pathology practices
      • 5.2.3.2. Increase in demand for personalized medicines
      • 5.2.3.3. High scope of growth in emerging economies
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of trained pathologists

6. ARTIFICIAL INTELLIGENCE IN DIGITAL PATHOLOGY

7. DIGITAL PATHOLOGY MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. SCANNERS
    • 7.2.1. SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2019
    • 7.2.2. BRIGHTFIELD SCANNERS
    • 7.2.3. FLUORESCENCE SCANNERS
    • 7.2.4. OTHER SCANNERS
  • 7.3. SOFTWARE
    • 7.3.1. DIGITAL PATHOLOGY SOFTWARE OFFER ANALYTICAL AND HIGHLY ADVANCED FUNCTIONS NOT OFFERED BY TRADITIONAL MICROSCOPES
    • 7.3.2. INFORMATION MANAGEMENT SOFTWARE
    • 7.3.3. IMAGE ANALYSIS SOFTWARE
    • 7.3.4. VISUALIZATION SOFTWARE
  • 7.4. COMMUNICATION SYSTEMS
    • 7.4.1. INTRODUCTION OF CLOUD-BASED COMMUNICATION SYSTEMS PROVIDES IMPETUS TO MARKET GROWTH
  • 7.5. STORAGE SYSTEMS
    • 7.5.1. APPLICATION OF PACS AND VNA TO DRIVE THE STORAGE SYSTEMS MARKET

8. DIGITAL PATHOLOGY MARKET, BY TYPE

  • 8.1. INTRODUCTION
  • 8.2. HUMAN PATHOLOGY
    • 8.2.1. HUMAN PATHOLOGY SEGMENT HELD THE LARGEST SHARE OF THE MARKET IN 2019
  • 8.3. VETERINARY PATHOLOGY
    • 8.3.1. VETERINARY DIGITAL PATHOLOGY CUTS THE TURNAROUND TIME FOR ANIMAL DISEASE DIAGNOSIS-A KEY FACTOR DRIVING MARKET GROWTH

9. DIGITAL PATHOLOGY MARKET, BY APPLICATION

  • 9.1. INTRODUCTION
  • 9.2. DRUG DISCOVERY
    • 9.2.1. INCREASES IN R&D SPENDING WILL PROVIDE IMPETUS TO DRUG DISCOVERY SEGMENT DURING THE FORECAST PERIOD.
  • 9.3. DISEASE DIAGNOSIS
    • 9.3.1. DISEASE DIAGNOSIS SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD.
  • 9.4. TELECONSULTATION
    • 9.4.1. THE NEED FOR ACCURATE, EFFICIENT, AND QUICK DIAGNOSIS IS EXPECTED TO DRIVE THE TELECONSULTATION MARKET DURING THE FORECAST PERIOD
  • 9.5. TRAINING & EDUCATION
    • 9.5.1. DIGITAL PATHOLOGY CAN IMPROVE DISTRIBUTION OF RARE AND EDUCATIONAL CASES FOR TRAINING

10. DIGITAL PATHOLOGY MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 10.2.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT IS ESTIMATED TO GROW AT THE HIGHEST CAGR DURING THE FORECAST
  • 10.3. HOSPITALS & REFERENCE LABORATORIES
    • 10.3.1. INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS IN HOSPITALS TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
  • 10.4. ACADEMIC & RESEARCH INSTITUTES
    • 10.4.1. ACADEMIC & RESEARCH INSTITUTES SEGMENT TO REGISTER STEADY GROWTH DURING THE FORECAST PERIOD

11. GLOBAL DIGITAL PATHOLOGY MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
      • 11.2.1.1. Favorable reimbursement scenario for digital pathology in the US
    • 11.2.2. CANADA
      • 11.2.2.1. Growing need for high-quality cancer diagnosis and government initiatives to drive the market growth in Canada
  • 11.3. EUROPE
    • 11.3.1. UK
      • 11.3.1.1. The UK to account for the largest share in the European market
    • 11.3.2. GERMANY
      • 11.3.2.1. High healthcare expenditure and supportive health insurance to drive the market growth in Germany
    • 11.3.3. SWEDEN
      • 11.3.3.1. Increasing government initiatives and deployment of digital pathology solutions
    • 11.3.4. DENMARK
      • 11.3.4.1. High cancer prevalence to drive the market growth in Denmark
    • 11.3.5. FRANCE
      • 11.3.5.1. Increasing incidences of cancer to drive the market growth during the forecast period
    • 11.3.6. REST OF EUROPE (ROE)
      • 11.3.6.1. Integration & deployment of digital pathology solutions in Rest of Europe
  • 11.4. ASIA PACIFIC
    • 11.4.1. CHINA
      • 11.4.1.1. Favorable initiatives for the adoption of telepathology in China
    • 11.4.2. JAPAN
      • 11.4.2.1. Initiatives are taken by industry players for cancer diagnosis
    • 11.4.3. INDIA
      • 11.4.3.1. Increasing incidences of cancer in India to drive the market growth
    • 11.4.4. REST OF ASIA PACIFIC (ROAPAC)
  • 11.5. REST OF THE WORLD
    • 11.5.1. LATIN AMERICA
      • 11.5.1.1. Increase in purchasing power and healthcare affordability to drive the market growth in LATAM countries
    • 11.5.2. MIDDLE EAST AND AFRICA
      • 11.5.2.1. Potential for the growth of the digital pathology market in this region

12. COMPETITIVE LANDSCAPE

  • 12.1. INTRODUCTION
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET) (2019)
    • 12.3.1. VISIONARY LEADERS
    • 12.3.2. INNOVATORS
    • 12.3.3. DYNAMIC DIFFERENTIATORS
    • 12.3.4. EMERGING COMPANIES
  • 12.4. COMPETITIVE SCENARIO
    • 12.4.1. KEY DEVELOPMENTS IN THE DIGITAL PATHOLOGY MARKET
    • 12.4.2. KEY PRODUCT LAUNCHES
    • 12.4.3. KEY ACQUISITIONS
    • 12.4.4. KEY EXPANSIONS

13. COMPANY PROFILES (Business overview, Products offered, Recent developments, Competitive analysis)*

  • 13.1. LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
  • 13.2. KONINKLIJKE PHILIPS
  • 13.3. HAMAMATSU PHOTONICS
  • 13.4. F. HOFFMANN-LA ROCHE LTD
  • 13.5. SECTRA AB
  • 13.6. 3DHISTECH
  • 13.7. APOLLO ENTERPRISE IMAGING
  • 13.8. XIFIN, INC.
  • 13.9. HURON DIGITAL PATHOLOGY
  • 13.10. VISIOPHARM
  • 13.11. CORISTA
  • 13.12. INDICA LABS
  • 13.13. OBJECTIVE PATHOLOGY SERVICES
  • 13.14. OPTRASCAN, INC.
  • 13.15. GLENCOE SOFTWARE, INC.
  • 13.16. OTHER COMPANIES
    • 13.16.1. KONFOONG BIOTECH INTERNATIONAL CO., LTD
    • 13.16.2. INSPIRATA, INC.
    • 13.16.3. MIKROSCAN TECHNOLOGIES, INC.
    • 13.16.4. PROSCIA INC
    • 13.16.5. KANTERON SYSTEMS

*Business overview, Products offered, Recent developments, Competitive analysis might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. AVAILABLE CUSTOMIZATIONS
  • 14.4. RELATED REPORTS
  • 14.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL CANCER INCIDENCE, 2018 VS. 2025
  • TABLE 2: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES, 2008-2016
  • TABLE 3: NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
  • TABLE 4: DIGITAL PATHOLOGY AI MARKET, BY REGION, 2018-2025 (MILLION)
  • TABLE 5: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 6: SCANNING MAGNIFICATION AND APPLICATIONS
  • TABLE 7: DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 8: DIGITAL PATHOLOGY SCANNERS MARKET, BY REGION, 2018-2025 (UNITS)
  • TABLE 9: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 10: BRIGHTFIELD SCANNERS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 11: FLUORESCENCE SCANNERS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12: OTHER SCANNERS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 13: TYPES OF DIGITAL PATHOLOGY SOFTWARE
  • TABLE 14: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 15: INFORMATION MANAGEMENT SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 16: IMAGE ANALYSIS SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 17: VISUALIZATION SOFTWARE MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 18: COMMUNICATION SYSTEMS USED IN DIGITAL PATHOLOGY
  • TABLE 19: DIGITAL PATHOLOGY COMMUNICATION SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 20: DIGITAL PATHOLOGY STORAGE SYSTEMS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 21: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 22: HUMAN DIGITAL PATHOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 23: VETERINARY DIGITAL PATHOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 24: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 25: APPLICATIONS OF DIGITAL PATHOLOGY IN DRUG DISCOVERY/RESEARCH:
  • TABLE 26: DIGITAL PATHOLOGY MARKET FOR DRUG DISCOVERY, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 27: DIGITAL PATHOLOGY MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 28: DIGITAL PATHOLOGY MARKET FOR TELECONSULTATION, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 29: DIGITAL PATHOLOGY MARKET FOR TRAINING & EDUCATION, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 30: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 31: DIGITAL PATHOLOGY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 32: HOSPITAL DEPLOYMENT OF DIGITAL PATHOLOGY SOLUTIONS 64  
  • TABLE 33: DIGITAL PATHOLOGY MARKET FOR HOSPITALS & REFERENCE LABORATORIES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 34: DIGITAL PATHOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 35: DIGITAL PATHOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 36: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 37: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 38: NORTH AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 39: NORTH AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 40: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 41: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 42: NORTH AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 43: CANCER CASES IN THE US, 2018
  • TABLE 44: CONFERENCES/MEETINGS/COURSES/WORKSHOPS HELD/TO BE HELD IN THE US
  • TABLE 45: US: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 46: US: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 47: US: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 48: US: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 49: US: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 50: US: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 51: CANADA: DIGITAL PATHOLOGY INITIATIVES AND FUNDING
  • TABLE 52: CANADA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 53: CANADA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 54: CANADA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 55: CANADA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 56: CANADA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 57: CANADA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025(USD MILLION)
  • TABLE 58: EUROPE: DIGITAL PATHOLOGY MARKET, BY COUNTRY/REGION, 2018-2025 (USD MILLION)
  • TABLE 59: EUROPE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 60: EUROPE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 61: EUROPE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 62: EUROPE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION) 82  
  • TABLE 63: EUROPE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 64: EUROPE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 65: CONFERENCES/COURSES HELD/TO BE HELD IN THE UK
  • TABLE 66: UK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 67: UK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 68: UK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 69: UK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 70: UK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 71: UK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 72: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025
  • TABLE 73: GERMANY: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 74: GERMANY: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 75: GERMANY: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 76: GERMANY: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 77: GERMANY: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 78: GERMANY: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 79: CANCER CASES IN SWEDEN, 2018
  • TABLE 80: SWEDEN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025(USD MILLION)
  • TABLE 81: SWEDEN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 82: SWEDEN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 83: SWEDEN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 84: SWEDEN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 85: SWEDEN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 86: DENMARK: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 87: DENMARK: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 88: DENMARK: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 89: DENMARK: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 90: DENMARK: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 91: DENMARK: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 92: CANCER INCIDENCE, BY TYPE, 2018 VS. 2025 96  
  • TABLE 93: FRANCE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 94: FRANCE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 95: FRANCE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 96: FRANCE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 97: FRANCE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 98: FRANCE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 99: ROE: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 100: ROE: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 101: ROE: DIGITAL PATHOLOGY SOFTWARE MARKET, BY SOFTWARE, 2018-2025 (USD MILLION)
  • TABLE 102: ROE: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 103: ROE: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 104: ROE: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 105: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 106: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 107: ASIA PACIFIC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 108: ASIA PACIFIC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY SOFTWARE, 2018-2025 (USD MILLION)
  • TABLE 109: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 110: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 111: ASIA PACIFIC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 112: CANCER CASES IN CHINA, 2018
  • TABLE 113: CHINA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 114: CHINA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 115: CHINA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 116: CHINA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 117: CHINA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 118: CHINA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 119: JAPAN: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 120: JAPAN: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 121: JAPAN: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 122: JAPAN: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION) 109  
  • TABLE 123: JAPAN: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 124: JAPAN: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 125: INDIA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 126: INDIA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 127: INDIA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 128: INDIA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 129: INDIA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 130: INDIA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 131: ROAPAC: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 132: ROAPAC: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 133: ROAPAC: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 134: ROAPAC: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 135: ROAPAC: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 136: ROAPAC: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 137: ROW: DIGITAL PATHOLOGY MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 138: ROW: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 139: ROW: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 140: ROW: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 141: ROW: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 142: ROW: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 143: ROW: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 144: LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 145: LATIN AMERICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 146: LATIN AMERICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 147: LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 148: LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 149: LATIN AMERICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 150: MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • TABLE 151: MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SCANNERS MARKET, BY TYPE, 2018-2025 (USD MILLION) 121  
  • TABLE 152: MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY SOFTWARE MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 153: MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 154: MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 155: MIDDLE EAST AND AFRICA: DIGITAL PATHOLOGY MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 156: PARTNERSHIPS AND COLLABORATIONS (2016-2019)
  • TABLE 157: PRODUCT LAUNCHES (2016-2019)
  • TABLE 158: ACQUISITIONS (2016-2019)
  • TABLE 159: EXPANSIONS (2016-2019)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: PRIMARY SOURCES
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY CATEGORY, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5: ILLUSTRATIVE EXAMPLE OF LEICA BIOSYSTEMS (SUBSIDIARY OF DANAHER CORPORATION)
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: DIGITAL PATHOLOGY MARKET ANALYSIS, BY PRODUCT (2020)
  • FIGURE 8: DIGITAL PATHOLOGY MARKET ANALYSIS, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9: DIGITAL PATHOLOGY MARKET ANALYSIS, BY APPLICATION, 2020 VS. 2025, (USD MILLION)
  • FIGURE 10: DIGITAL PATHOLOGY MARKET ANALYSIS, BY END USER, 2020 VS. 2025, (USD MILLION)
  • FIGURE 11: NORTH AMERICA MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: INCREASING ADOPTION OF DIGITAL PATHOLOGY SOLUTIONS TO DRIVE THE MARKET
  • FIGURE 13: SCANNERS ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN DIGITAL PATHOLOGY MARKET IN 2019
  • FIGURE 14: NORTH AMERICA TO WITNESS THE HIGHEST GROWTH IN THE DIGITAL PATHOLOGY MARKET FROM 2020 TO 2025
  • FIGURE 15: DIGITAL PATHOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: DIGITAL PATHOLOGY MARKET, BY REGION, 2019
  • FIGURE 17: NORTH AMERICA: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 18: EUROPE: DIGITAL PATHOLOGY MARKET SNAPSHOT
  • FIGURE 19: CANCER PREVALENCE IN DENMARK
  • FIGURE 20: VALUE-BASED MARKET SHARES OF KEY PLAYERS, 2019
  • FIGURE 21: DIGITAL PATHOLOGY MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 22: DANAHER CORPORATION: COMPANY SNAPSHOT (2019)
  • FIGURE 23: KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2019)
  • FIGURE 24: HAMAMATSU PHOTONICS: COMPANY SNAPSHOT (2019)
  • FIGURE 25: F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT (2019)
  • FIGURE 26: SECTRA AB: COMPANY SNAPSHOT (2018)
Back to Top